Summary of Purpose
Stroke is among the most disabilitating diseases worldwide in terms of numbers affected and its consequences. A relatively new and well documented treatment of acute ischemic stroke today is tPA (tissue plasminogen activator; will be called thrombolysis from now on) Unfortunately only a minority of patients is given this treatment. The large randomised controlled trials that investigated the safety and efficacy...Read More →
The following dates are available for this trial. Trial information last updated on 20 December 2011.
|1 Jan 2007||6 Jul 2011||1 Feb 2010||1 Feb 2010||1 Dec 2011||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Observation: Cohort
- Perspective: Prospective
- Sampling: Probability Sample